• Developmental SSRI Exposure Impairs Motivation via Opioid Ci

  2026-07-25

  This study reveals that developmental exposure to selective serotonin reuptake inhibitors (SSRIs) in mice leads to persistent motivational deficits extending into adolescence and adulthood. Notably, these deficits are resistant to further SSRI treatment but can be specifically reversed by pharmacological antagonism or viral knockdown of mu opioid receptors in the nucleus accumbens, highlighting a critical serotonergic-opioid circuit interaction relevant for depression research.

• Cisplatin (CDDP): Systems-Level Insights for Tumor Modeling

  2026-07-24

  Discover how Cisplatin enables systems-level analysis of tumor growth inhibition and chemoresistance. This in-depth article explores advanced applications, experimental design, and translational implications for cancer research.

• HRD1-SEL1L Ubiquitin Ligase Regulates Stress Granule Homeost

  2026-07-24

  Shi et al. (2024) demonstrate that the HRD1-SEL1L ubiquitin ligase complex, through the ubiquitin-proteasome system and ER stress signaling, specifically maintains heat shock-induced stress granule (SG) homeostasis. This mechanistic insight links proteostasis, selective ER stress pathways, and SG dynamics, informing future studies on neurodegeneration and proteinopathy.

• Phosphatase Inhibitor Cocktail 3: Enhancing Phosphoprotein A

  2026-07-23

  Phosphatase Inhibitor Cocktail 3 (100X in DMSO) empowers researchers to reliably preserve protein phosphorylation during extraction and analysis, enabling robust, reproducible phosphoproteomics. This APExBIO solution is tailored for workflows demanding precise serine/threonine phosphatase inhibition, especially in studies of dynamic cell signaling and bone biology.

• Novel Allosteric PDK4 Inhibitors: Insights for Metabolic Dis

  2026-07-23

  This article examines the discovery and characterization of novel allosteric inhibitors targeting pyruvate dehydrogenase kinase 4 (PDK4), as reported in a recent medicinal chemistry study. The reference work identifies compounds with nanomolar potency, metabolic stability, and in vivo efficacy, providing a new scaffold for modulating mitochondrial energy metabolism in models of metabolic disease, allergy, and cancer.

• EdU Imaging Kits (488): Decoding Proliferation in CRC and Be

  2026-07-22

  Explore the scientific depth of EdU Imaging Kits (488) for cell proliferation analysis, with a focus on S-phase DNA synthesis and advanced colorectal cancer research. This article reveals how mechanistic insights and innovative assay design empower next-generation cell cycle studies.

• Applied Workflows with mCherry mRNA: Stability, Expression &

  2026-07-22

  EZ Cap™ mCherry mRNA (5mCTP, ψUTP) from APExBIO enables robust, immune-evasive fluorescent protein expression for advanced cell and molecular workflows. Explore optimized protocols, innovative nanoparticle delivery, and practical troubleshooting strategies to maximize reporter gene mRNA performance.

• Flexible 3D Nanocluster Arrays via Polymer Pen Lithography f

  2026-07-21

  The reference study demonstrates a scalable, programmable approach for fabricating highly ordered three-dimensional gold nanocluster arrays using polymer pen lithography. By tuning pattern parameters, the method delivers exceptional SERS sensitivity and reproducibility, advancing practical biosensing and analytical detection platforms.

• Rhodamine 123 (chloride): Precision Tools for ABC Transporte

  2026-07-21

  Rhodamine 123 (chloride) from APExBIO transforms real-time membrane transport analysis with high-sensitivity, quantitative workflows for P-glycoprotein and OATP1A2 research. Discover advanced protocol optimizations, troubleshooting strategies, and insights from recent breakthroughs in multidrug resistance modulation.

• α-Bungarotoxin in Translational Cholinergic Research: Mechan

  2026-07-20

  Explore how α-Bungarotoxin enables precise nicotinic receptor blockade for advanced neuroscience and placental necroptosis studies. This article uniquely integrates mechanistic detail and translational assay design, offering a deeper perspective for cholinergic neurotransmission inhibition.

• AI-Driven Radiopathomics Predicts Immunotherapy Response in

  2026-07-20

  This study presents a multimodal radiopathomics signature (RPS) developed using interpretable machine learning to predict response to immunotherapy-based combination therapy in gastric cancer. Integrating CT and digital pathology data, the RPS outperforms conventional biomarkers and reveals new insights into immune regulation, offering a robust tool for patient stratification and treatment planning.

• Idoxuridine: Precision Antiviral Workflows for DNA Synthesis

  2026-07-19

  Idoxuridine (5-iodo-2'-deoxyuridine) is a benchmark antiviral agent for dissecting viral DNA synthesis and replication inhibition, enabling robust, reproducible workflows in both classic and emerging research domains. This article translates cutting-edge findings and expert troubleshooting into actionable protocols, highlighting APExBIO’s research-grade Idoxuridine as the gold standard for antiviral and mechanistic studies.

• PYR-41, Inhibitor of Ubiquitin-Activating Enzyme E1: Advance

  2026-07-18

  PYR-41, a selective inhibitor of Ubiquitin-Activating Enzyme E1, revolutionizes research on protein degradation and inflammatory signaling by enabling precise, reproducible control of the ubiquitin-proteasome system. This article delivers actionable experimental workflows, advanced troubleshooting, and practical insights for leveraging PYR-41 in cutting-edge cellular and in vivo models.

• EdU Imaging Kits (488): Advancing S-Phase DNA Synthesis Meas

  2026-07-17

  EdU Imaging Kits (488) elevate cell proliferation assays by enabling non-destructive, highly sensitive S-phase DNA synthesis detection using click chemistry. Their streamlined workflow and superior preservation of cell morphology distinguish them from BrdU-based methods, making them an optimal choice for advanced research in cancer biology and regenerative medicine.

• Disrupting SARS-CoV-2 N Protein Phase Separation With GCG: M

  2026-07-17

  The referenced study uncovers how the SARS-CoV-2 nucleocapsid (N) protein undergoes RNA-triggered liquid–liquid phase separation (LLPS), a critical process for viral replication and assembly. It further demonstrates that (-)-gallocatechin gallate (GCG) can inhibit this phase separation, thereby suppressing viral replication—offering a mechanistic foundation for antiviral strategy development.

15762 records 1/1051 page Next 12345 下5页 Last page